Plain-English translation of NCT06839716 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a numbing medication called Ropivacaine-Poloxamer 407 hydrogel—applied directly to the surgical wound—works as well as a nerve block injection for controlling pain after stomach cancer surgery. Researchers want to understand which approach helps patients recover better and manage pain more effectively after this type of surgery.
After stomach surgery, pain management is critical for recovery. Doctors currently use different techniques to numb the surgical area, but it's not clear which method works best. This study will help guide doctors on the most effective way to keep patients comfortable after minimally invasive stomach cancer surgery.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the numbing gel applied to your surgical wound or a nerve block injection during surgery. Both are standard pain-relief techniques—this study simply compares which works better. After surgery, researchers will monitor your pain levels and recovery over a defined period to see which method provides superior pain control and helps you heal faster.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea